Healthcare Industry News: ultrasound
News Release - May 9, 2016
Signostics Launches Uscan(TM) in Europe - the World's First Smart Mobile-connected Visualisation Device Specialised for Urologic CareUscan provides urologic visualisation for efficient and more confident point-of-care clinical decision-making
LONDON, May 9, 2016 -- (Healthcare Sales & Marketing Network) -- Signostics, the global innovator in smart, high reliability ultrasound devices for urology, announced today that it has launched Uscan™ in Europe, the first smart mobile-connected ultrasound visualisation device targeted at urologic care.
Using algorithms from the science of computer vision, Uscan actively recognises the 3D contours of the bladder, for far more accurate volume measurements than the industry standard* even on obese and other hard-to-scan patients. It acquires up to 256 bladder slices - 32 times more than conventional bladder scanners - resulting in industry-leading accuracy. It also provides real-time ultrasound imaging of the kidneys, pelvic floor, prostate, gallbladder, bladder stones, and catheter emplacement, for quick and easy visual tracking and observation.
"Uscan doesn't just scan; it sees - providing intelligent urologic visualisation by leveraging science from current-day computer vision algorithms aimed at more efficient and confident point-of-care clinical decision-making," said Kevin Goodwin, CEO. "Uscan will exceed historical industry standards for bladder volume measurement accuracy yet will also enable use for other urologic imaging needs, reducing the delays and expense of engaging specialised ultrasound equipment or sonographers."
Uscan also offers integrated middleware not found in any comparably priced systems; and can be used in a range of clinical settings beyond urology, including the emergency department, maternity, paediatrics, oncology, rehabilitation, aged care and home nursing. The system's removable probe, high-resolution touch screen tablet and handheld displays make it ideally suited for on-the-go clinical care.
Speaking specifically on the impact Uscan will have on patient care, Hannes Scheibl, General Manager for Signostics Europe said, "We know healthcare professionals have long been accustomed to using conventional handheld scanners to measure bladder volume. Technological innovations and the adoption of advances in microprocessing and software mean that much more could be achieved for patients. Uscan puts smart ultrasound imaging in the hands of all members of the clinical care team for efficient and confident point-of-care clinical decision-making to inform treatment decisions, streamline workflows, and ultimately inform treatment of a wider range of patients."
It is compatible with Android operating systems, and has built-in WiFi and Bluetooth connectivity that enables fast and reliable image management and interoperability with electronic health record (EHR) systems.
Uscan also offers the industry's lowest cost of ownership in this market space, coming with a designed- in 5-year product warranty, with a "no small print" pledge and requires no annual calibration. It is simple to learn and use, and provides real-time user guidance, eliminating the need for extensive training.
Uscan is now available across Europe for product demonstrations and will be commercially available by June 2016. For product information and enquiries, please contact Hannes Scheibl: email@example.com.
Signostics Inc. is a wholly-owned subsidiary of Signostics Limited, a global medical device manufacturer. A KKR portfolio company, Signostics is pioneering smart ultrasound devices to enhance imaging and clinical decision making in urologic care. The company's products include Uscan, SignosRT ultrasound systems and the SignosRT Bladder Scanner - ultra-portable, affordable devices designed to assist with the diagnosis of common medical presentations at the bedside. The company has regulatory approvals in the U.S., Australia, Canada, Europe, Singapore and Japan, and exports to countries around the world. For more information, visit eu.signosticsmedical.com.
Signostics and Uscan are Trademarks of Signostics Limited.
*Based on comparative measurements of a phantom of known volume.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.